ACXP
ACXP
NASDAQ · Biotechnology

Acurx Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.94
-0.05 (-2.51%)
As of May 16, 2:33 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +916.5% upside
Low Target $18.07
Average Target $19.72
High Target $32.84
Current Price $1.94
Current
$1.94
Target
$19.72
$18.07 $19.72 avg $32.84
Scenario Analysis
Bear Case
$18.07
831.4%
Low target
Base Case
$19.72
+916.5%
Avg target
Bull Case
$32.84
+1,592.8%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$21.00
-90.8% from high
52-Week Low
$1.33
+46.3% from low
Target vs 52W High
$19.72
-6.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%